Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate...

Descripción completa

Detalles Bibliográficos
Autores principales: Pemmaraju, Naveen, Sweet, Kendra L., Stein, Anthony S., Wang, Eunice S., Rizzieri, David A., Vasu, Sumithira, Rosenblat, Todd L., Brooks, Christopher L., Habboubi, Nassir, Mughal, Tariq I., Kantarjian, Hagop, Konopleva, Marina, Lane, Andrew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
CLINICAL TRIAL UPDATES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462530/
https://www.ncbi.nlm.nih.gov/pubmed/35820082
http://dx.doi.org/10.1200/JCO.22.00034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462530/
https://www.ncbi.nlm.nih.gov/pubmed/35820082
http://dx.doi.org/10.1200/JCO.22.00034

Ejemplares similares